Medications and Older Adults



Medications and Older Adults


Objectives



1. Identify factors that increase the risk for medication-related problems.


2. Discuss the reasons each of these factors increases health risks for the aging person.


3. Describe how pharmacokinetics is altered with aging.


4. Discuss the pharmacodynamic changes observed in the aging person.


5. Identify the significance of the Beers criteria.


6. Explain specific precautions that are necessary when administering medication to older adults in an institutional setting.


7. Identify the risks related to aging and pertinent nursing observations for specific drug categories.


8. Discuss how medications fit into the nursing plan of care.


9. Describe specific nursing interventions and modifications in technique that are related to medication administration to older adults.


10. Describe the older person’s rights as they relate to medication administration.


11. Identify information that should be provided to older adults regarding medications.


12. Discuss the impact of age-related changes on self-administration of medications.


13. Describe nursing interventions that can reduce problems related to self-administration of medication in the home.


Key Terms


absorption (ăb-SŎRP-shŭn) (p. 132)


distribution (dimages-trimage-BŬ-shŭn) (p. 132)


excretion (ĕks-KRĒ-shŭn) (p. 133)


geropharmacology (jĕr-ō-făr-mă-KŌL-ŏ-jē) (p. 132)


half-life (p. 132)


metabolism (mĕ-TĂB-ō-lĬzm) (p. 133)


pharmacokinetics (făr-mă-kō-kĬ-NĔT-Ĭks) (p. 132)


polypharmacy (pŏ-lē-FĂR-mă-sē) (p. 133)


imagehttp://evolve.elsevier.com/Wold/geriatric


Problems related to medications are common in older adults, and they are costly in terms of both time and money. Medications can alter an aging person’s ability to perform normal functions, can result in behavior changes, and can be life threatening. Adverse reactions to medications are common in older adults. Studies have revealed that as many as 17% of hospitalizations of persons older than 66 years of age were related to adverse drug reactions. In addition, one in three older persons is likely to develop iatrogenic (treatment-related) complications secondary to medications taken during a hospital stay. Adverse drug reactions also have been linked to an increased risk for falls and automobile accidents. Studies show that the resulting hospitalizations cost older adults and taxpayers several billion dollars each year.


Estimates indicate that the average person older than 65 years of age takes three or more prescription medications each day. In addition, the average older person also takes three or four nonprescription medications obtained over the counter (OTC). The cost of these medications exceeds $3 billion per year. Studies have shown that 40% of all prescription drugs are written for people age 65 and older. Many elderly prefer to try self treatment with OTC medications before consulting a physician. Studies show that older adults purchase 40% of the OTCs sold and that 90% of this group use OTC drugs at least occasionally.


Considering these numbers, it is no surprise that use, misuse, and abuse of medications present serious threats to the aging population. Medications are potent substances. For every desired effect, many side effects and adverse effects are likely to occur. Although often useful or necessary to maintain health, medications present risks to people of all ages, and older adults are at even greater risk than the younger population (Box 7-1).



Risks related to drug-testing methods


In general, the methodology used to test drugs and to establish therapeutic dosages does not take into account the unique characteristics of older adults. Most drug testing is performed on healthy, young adult men. Because older adults normally have had some changes in body function and are more likely to suffer from at least one disease process, they are not physiologically the same as young adults. It seems obvious that an 80-year-old, 94-pound woman with heart disease should not be expected to respond in the same way that a healthy 35-year-old, 200-pound man would. The drugs and dosages that are appropriate for one may be unsuitable for the other. No medical professional would think of giving an adult dose of medication to a child, yet the same consideration is not always given to the unique situation presented by older adults. Geropharmacology, the study of how older adults respond to medication, is a new but growing area. Until all physicians recognize the uniqueness of older adults and modify treatment accordingly, overmedication is likely to occur.


Risks related to the physiologic changes of aging


People do not experience age-related physiologic changes at the same rate. When considering the responses of older adults to medication, it is more important to consider physiologic age than chronologic age. The more physiologic changes experienced, the greater the risk will be of an altered response to medications. Even the most common physiologic changes of aging can have a significant effect on pharmacokinetics and pharmacodynamics (Table 7-1).



Pharmacokinetics


Pharmacokinetics is the study of drug actions within the body, including absorption, distribution, metabolism, and excretion.


Drug Absorption


Most medications are taken orally and are absorbed through the gastrointestinal tract. Gastric acid secretion decreases as we age, resulting in an increased gastric pH. When the concentration of acid is lower than normal, drug absorption is reduced. Decreased acidity also affects the breakdown of capsules and tablet coatings in the stomach, resulting in a variable absorption rate, depending on the way a drug is manufactured.


Decreased gastric motility and a slower emptying rate of the stomach are common with aging. These can increase the amount of time that the medication is in contact with the gastric mucosa and can lead to increased absorption. Decreased peristalsis can also affect the speed at which enteric medication reaches the intestine. It may take longer for a drug to reach its site of absorption; therefore, its onset of action may be delayed. Changes in the ability of the cells in the gastrointestinal tract to absorb and transport the drug can further influence its absorption. If medication is not transferred effectively through the cell membrane, the amount of absorption will be decreased.


Drug Distribution


With aging, there is typically a decrease in total body mass, lean body mass, and total body water and an increase in total body fat. These changes can significantly alter the distribution of medications. Because there is less total body water, water-soluble drugs such as gentamicin, histamine-receptor blockers, and lithium tend to remain in higher concentrations in the bloodstream. This results in increased blood concentration levels of these drugs. An older person who is dehydrated is at even greater risk for reaching excessive blood levels of water-soluble drugs.


As muscle mass decreases and the percentage of adipose tissue increases, fat-soluble drugs such as phenobarbital and the benzodiazepines become trapped in the fatty tissue, resulting in abnormally low blood levels. If the dosage is increased based on these blood levels, an excessive amount of medication may be administered. Because fat-soluble drugs continue to be released slowly from the fat into the bloodstream, older persons may exhibit delayed or hangover effects. The half-life of a single dose of diazepam, which is 36 hours in a young adult, may extend to as much as 100 hours in an older individual.


A decrease in hemoglobin and the plasma protein albumin is common with aging. This results in fewer available sites for protein-bound drugs such as warfarin, phenytoin, theophylline, salicylates, and tolbutamide. The danger of adverse or toxic reactions is high even with smaller doses, because an unbound active drug still circulates in the bloodstream. The risk for toxicity is greater in malnourished older adults. Aging persons who consume high-carbohydrate, low-protein diets are more likely to develop toxicity than are aging persons who consume a well-balanced diet. Because not all of the serum drug assays can distinguish between free and bound medications, these tests may not provide reliable measures of toxicity.


Drug Metabolism


The liver is the primary site of drug metabolism. Aging often results in decreased activity of liver cells, decreased metabolic enzymes, and decreased cardiac output, which results in reduced blood flow to the liver. By 65 years of age, the liver has only 55% to 65% of the perfusion of a young adult. This reduction in perfusion decreases the liver’s effectiveness in metabolizing drugs. When drugs are not metabolized effectively by the older adult’s liver, the risk for toxicity increases. Toxicity is always a concern with medications commonly prescribed for older adults, including digoxin, β-blockers, calcium-channel blockers, and tricyclic antidepressants.


Drug Excretion


Aging kidneys are significantly less effective at removing waste products, including the by-products of medications. As the kidneys become less effective in the excretion of drugs, more drug remains in the circulation, leading to elevated drug levels and symptoms of drug toxicity. Circulatory changes that reduce blood flow to the kidneys result in drug accumulation in the bloodstream and increase the risk for toxicity.


Because the changes in kidney function are accompanied by changes in lean body mass, serum creatinine levels often remain constant, masking the decline in function. When the risks for toxicity are assessed, creatinine clearance tests provide a more effective measure of kidney function than does the serum creatinine level.


Medications such as aminoglycosides, digoxin, lithium, procainamide, and cimetidine are likely to reach toxic levels because of poor renal excretion. Non-prescription drugs such as alcohol and nicotine can also affect kidney function and cause changes in drug elimination in older persons.


Pharmacodynamics


Responses to medications are less predictable in the aging person. Pathologic changes in target organs may affect the response to medications. Receptor sites on the target organs may respond more or less sensitively to medications. The receptors may respond normally to some medications but not to others. Receptors often may be more sensitive to medications, placing older adults at increased risk for toxic responses. Brain receptors are particularly sensitive, thus the strong response of most older persons to psychotropic medications. When the receptor sites are less sensitive, the individual may require larger-than-normal doses to achieve therapeutic effects. If receptor sites in the myocardium are affected, older persons may require higher doses of common medications such as propranolol and lidocaine. Administration of these higher doses increases the risk for toxicity.


Polypharmacy


Polypharmacy, the prescription, administration, or use of more medications than are clinically indicated, is a common problem in older adults (Figure 7-1). According to many studies, older adults ingest a far greater number of medications than do younger persons. A recent survey revealed that the average institutionalized older person takes 7.5 medications. Nearly 10% of those living independently take as many as 12 prescription drugs. This number does not include OTC medications that may be taken with or without a physician’s recommendation or knowledge. It is estimated that older adults purchase 40% of all nonprescription medications. The more medications taken, the greater the risk for untoward reactions, drug interactions, and drug toxicities. Drug interactions and toxicities in older adults are likely to result in behavioral or cognitive changes, which are often mistaken for dementia.



Many factors contribute to the increased usage of medication among older adults, including an increased likelihood of multiple acute or chronic disease conditions, increased availability of a variety of prescription and OTC medications, changes in patient expectations, and changes in the health care delivery system.


Newer, better, and more potent medications are developed every day. Medical conditions of older adults that were once considered untreatable are now treated routinely using medications. Because older adults tend to have more physical complaints or diseases than do younger individuals, medication usage increases exponentially.


Older adults seek medical intervention for many reasons. Some live with their problems and seek medical attention only when they have serious concerns. By the time such a person seeks medical attention, his or her condition may have seriously deteriorated, requiring the prescription of multiple medications. Other older persons make frequent visits to their physicians, seeking reassurance that nothing is seriously wrong. Rather than spending the time needed to reassure older adults, some physicians issue a prescription as a way to terminate the visit. Unfortunately, this poor medical practice occurs too often and can result in older adults taking unnecessary or marginally necessary medications.


Still other older persons expect their physicians to be able to eliminate all of their problems and ailments with medications. Every television show, magazine article, or recommendation from a friend extolling the benefits of a new medication sends some older adults to their doctors’ offices to request or even demand the new medicine. They expect the physician to provide a medication to relieve their ailments, and they often perceive that the physician is not doing anything for them unless some medication is prescribed. Some older adults even go from doctor to doctor until they find one who will give them what they want. Under these pressures, some physicians prescribe medications that they otherwise would not have ordered.


Changes in health care delivery, particularly increased medical specialization, have contributed to medication-related problems. It is increasingly common for an older person to have two or more physicians providing their care. When more than one physician writes prescriptions, the risk for medication reactions and overmedication increases dramatically. If a physician does not know what drugs the patient is already taking, he or she cannot consider those drugs when determining the safety of another prescription. Every physician providing care to an older person must be aware of all medications that person is taking, no matter who prescribed them.



Beers criteria for potentially inappropriate medication use in older adults


The fact that older adults respond differently than younger adults has been recognized for some time. Until recently, there were no specific guidelines to aid the physician in selection of medications least likely to cause adverse reactions. In 1991, the Beers Criteria, a list of drugs that should usually be avoided by the elderly, was developed. This list was improved and expanded in 1997 and again in 2002. Two separate lists now exist. Part I identifies medications best avoided by the elderly independent of diagnoses or conditions (Table 7-2). Part II uses diagnoses or conditions as the primary consideration (Table 7-3 on pages 138–139). Medicare and Medicaid have developed regulations for skilled nursing facilities that are heavily based on the Beers criteria. Skilled care facilities are required to have protocols that ensure that physician’s orders are in compliance. Citations are issued to facilities that fail to comply.



image Table 7-2


2002 Criteria for Potentially Inappropriate Medication Use in Older Adults: Independent of Diagnoses or Conditions – Beer’s Criteria












































































































































































































Drug Concern Severity Rating (High or Low)
Propoxyphene (Darvon) and combination products (Darvon with ASA, Darvon-N, and Darvocet-N)* Offers few analgesic advantages over acetaminophen, yet has the adverse effects of other narcotic drugs. Low
Indomethacin (Indocin and Indocin SR) Of all available nonsteroidal anti-inflammatory drugs, this drug produces the most CNS adverse effects. High
Pentazocine (Talwin) Narcotic analgesic that causes more CNS adverse effects, including confusion and hallucinations, more commonly than other narcotic drugs. Additionally, it is a mixed agonist and antagonist. High
Trimethobenzamide (Tigan) One of the least effective antiemetic drugs, yet it can cause extrapyramidal adverse effects. High
Muscle relaxants and antispasmodics: methocarbamol (Robaxin), carisoprodol (Soma), chlorzoxazone (Paraflex),metaxalone (Skelaxin), cyclobenzaprine (Flexeril), and oxybutynin (Ditropan). Do not consider the extended-release Ditropan XL. Most muscle relaxants and antispasmodic drugs are poorly tolerated by elderly patients, since these cause anticholinergic adverse effects, sedation, and weakness. Additionally, their effectiveness at doses tolerated by elderly patients is questionable. High
Flurazepam (Dalmane) This benzodiazepine hypnotic has an extremely long half-life in elderly patients (often days), producing prolonged sedation and increasing the incidence of falls and fracture. Medium- or short-acting benzodiazepines are preferable. High
Amitriptyline (Elavil), chlordiazepoxide-amitriptyline (Limbitrol), and perphenazine-amitriptyline (Triavil) Because of its strong anticholinergic and sedation properties, amitriptyline is rarely the antidepressant of choice for elderly patients. High
Doxepin (Sinequan) Because of its strong anticholinergic and sedating properties, doxepin is rarely the antidepressant of choice for elderly patients. High
Meprobamate (Miltown and Equanil) This is a highly addictive and sedating anxiolytic. Those using meprobamate for prolonged periods may become addicted and may need to be withdrawn slowly. High
Doses of short-acting benzodiazepines: doses greater than lorazepam (Ativan), 3 mg; oxazepam (Serax), 60 mg; alprazolam (Xanax), 2 mg; temazepam (Restoril), 15 mg; and triazolam (Halcion), 0.25 mg Because of increased sensitivity to benzoadiazepines in elderly patients, smaller doses may be effective as well as safer. Total daily doses should rarely exceed the suggested maximums. High
Long-acting benzodiazepines: chlordiazepoxide (Librium), chlordiazepoxide-amitriptyline (Limbitrol) clidiniumchlordiazepoxide (Librax), diazepam (Valium), quazepam (Doral), halazepam (Paxipam), and chlorazepate (Tranxene) These drugs have a long half-life in elderly patients (often several days), producing prolonged sedation and increasing the risk of falls and fractures. Short- and intermediate-acting benzodiazepines are preferred if a benzodiazepine is required. High
Disopyramide (Norpace and Norpace CR) Of all antiarrhythmic drugs, this is the most potent negative inotrope and therefore may induce heart failure in elderly patients. It is also strongly anticholinergic. Other antiarrhythmic drugs should be used. High
Digoxin (Lanoxin) (should not exceed >0.125 mg/d except when treating atrial arrhythmias) Decreased renal clearance may lead to increased risk of toxic effects. Low
Short-acting dipyridamole (Persantine). Do not consider the long-acting dipyridamole (which has better properties than the short-acting in older adults) except with patients with artificial heart valves May cause orthostatic hypotension. Low
Methyldopa (Aldomet) and methyldopa-hydrochlorothiazide (Aldoril) May cause bradycardia and exacerbate depression in elderly patients. High
Reserpine at doses >0.25 mg May induce depression, impotence, sedation, and orthostatic hypotension. Low
Chlorpropamide (Diabinese) It has a prolonged half-life in elderly patients and could cause prolonged hypoglycemia. Additionally, it is the only oral hypoglycemic agent that causes SIADH. High
Gastrointestinal antispasmodic drugs: dicyclomine (Bentyl), hyoscyamine (Levsin and Levsinex), propantheline (Pro-Banthine), belladonna alkaloids (Donnatal and others), and clidinium-chlordiazepoxide (Librax) GI antispasmodic drugs are highly anticholinergic and have uncertain effectiveness. These drugs should be avoided (especially for long-term use). High
Anticholinergics and antihistamines: chlorpheniramine (Chlor-Trimeton), diphenhydramine (Benadryl), hydroxyzine (Vistaril and Atarax), cyproheptadine (Periactin), promethazine (Phenergan), tripelennamine, dexchlorpheniramine (Polaramine) All nonprescription and many prescription antihistamines may have potent anticholinergic properties. Nonanticholinergic antihistamines are preferred in elderly patients when treating allergic reactions. High
Diphenhydramine (Benadryl) May cause confusion and sedation. Should not be used as a hypnotic, and when used to treat emergency allergic reactions, it should be used in the smallest possible dose. High
Ergot mesyloids (Hydergine) and cyclandelate (Cyclospasmol) Have not been shown to be effective in the doses studied. Low
Ferrous sulfate >325 mg/d Doses >325 mg/d do not dramatically increase the amount absorbed but greatly increase the incidence of constipation. Low
All barbiturates (except phenobarbital) except when used to control seizures Are highly addictive and cause more adverse effects than most sedative or hypnotic drugs in elderly patients. High
Meperidine (Demerol) Not an effective oral analgesic in doses commonly used. May cause confusion and has many disadvantages to other narcotic drugs. High
Ticlopidine (Ticlid) Has been shown to be no better than aspirin in preventing clotting and may be considerably more toxic. Safer, more effective alternatives exist. High
Ketorolac (Toradol) Immediate and long-term use should be avoided in older persons, since a significant number have asymptomatic GI pathologic conditions. High
Amphetamines and anorexic agents These drugs have potential for causing dependence, hypertension, angina, and myocardial infarction. High
Long-term use of full-dosage, longer half-life, non–COX-selective NSAIDs: naproxen (Naprosyn, Avaprox, and Aleve), oxaprozin (Daypro), and piroxicam (Feldene) Have the potential to produce GI bleeding, renal failure, high blood pressure, and heart failure. High
Daily fluoxetine (Prozac) Long half-life of drug and risk of producing excessive CNS stimulation, sleep disturbances, and increasing agitation. Safer alternatives exist. High
Long-term use of stimulant laxatives: bisacodyl (Dulcolax), cascara sagrada, and Neoloid except in the presence of opiate analgesic use May exacerbate bowel dysfunction. High
Amiodarone (Cordarone) Associated with QT interval problems and risk of provoking torsades de pointes. Lack of efficacy in older adults. High
Orphenadrine (Norflex) Causes more sedation and anticholinergic adverse effects than safer alternatives. High
Guanethidine (Ismelin) May cause orthostatic hypotension. Safer alternatives exist. High
Guanadrel (Hylorel) May cause orthostatic hypotension. High
Cyclandelate (Cyclospasmol) Lack of efficacy. Low
Isoxsurpine (Vasodilan) Lack of efficacy. Low
Nitrofurantoin (Macrodantin) Potential for renal impairment. Safer alternatives available. High
Doxazosin (Cardura) Potential for hypotension, dry mouth, and urinary problems. Low
Methyltestosterone (Android, Virilon, and Testrad) Potential for prostatic hypertrophy and cardiac problems. High
Thioridazine (Mellaril) Greater potential for CNS and extrapyramidal adverse effects. High
Mesoridazine (Serentil) CNS and extrapyramidal adverse effects. High
Short acting nifedipine (Procardia and Adalat) Potential for hypotension and constipation. High
Clonidine (Catapres) Potential for orthostatic hypotension and CNS adverse effects. Low
Mineral oil Potential for aspiration and adverse effects. Safer alternatives available. High
Cimetidine (Tagamet) CNS adverse effects including confusion. Low
Ethacrynic acid (Edecrin) Potential for hypertension and fluid imbalances. Safer alternatives available. Low
Desiccated thyroid Concerns about cardiac effects. Safer alternatives available. High
Amphetamines (excluding methylphenidate hydrochloride and anorexics) CNS stimulant adverse effects. High
Estrogens only (oral) Evidence of the carcinogenic (breast and endometrial cancer) potential of these agents and lack of cardioprotective effect in older women. Low

Abbreviations: CNS, central nervous system; COX, cyclooxygenase; GI, gastrointestinal; NSAIDs, nonsteroidal anti-inflammatory drugs; SIADH, syndrome of inappropriate antidiuretic hormone secretion.


*Proxyphene and its combination products were recalled by the FDA in November, 2010, because of the risk of serious or possibly fatal heart rhythm abnormalities. These drugs should no longer be prescribed or administered.


Reprinted with permission: Fick, D.M., Cooper, J.W., Wade, W.E., Waller, J.L., Maclean, J.R., & Beers, M.H. (2003). Updating the Beers Criteria for potentially inappropriate medication use in older adults: Results of a US consensus panel of experts. Archives of Internal Medicine, 163(22), 2716–2724. Table 1, p. 2720. Evidence Level VI: Expert Opinion. Copyright © 2003, American Medical Association. All Rights reserved.



image Table 7-3


2002 Criteria for Potentially Inappropriate Medication Use in Older Adults: Considering Diagnoses or Conditions









































































































Disease or Condition Drug Concern Severity Rating (High or Low)
Heart failure Disopyramide (Norpace), and high sodium content drugs (sodium and sodium salts [alginate bicarbonate, biphosphate, citrate, phosphate, salicylate, and sulfate]) Negative inotropic effect. Potential to promote fluid retention and exacerbation of heart failure. High
Hypertension Phenylpropanolamine hydrochloride (removed from the market in 2001), pseudoephedrine; diet pills, and amphetamines May produce elevation of blood pressure secondary to sympathomimetic activity. High
Gastric or duodenal ulcers NSAIDs and aspirin (>325 mg) (coxibs excluded) May exacerbate existing ulcers or produce new/ additional ulcers. High
Seizures or epilepsy Clozapine (Clozaril), chlorpromazine (Thorazine), thioridazine (Mellaril), and thiothixene (Navane) May lower seizure thresholds. High
Blood clotting disorders or receiving anticoagulant therapy Aspirin, NSAIDs, dipyridamole (Persantin), ticlopidine (Ticlid), and clopidogrel (Plavix) May prolong clotting time and elevate INR values or inhibit platelet aggregation, resulting in an increased potential for bleeding. High
Bladder outflow obstruction Anticholinergics and antihistamines, gastrointestinal antispasmodics, muscle relaxants, oxybutynin (Ditropan), flavoxate (Urispas), anticholinergics, antidepressants, decongestants, and tolterodine (Detrol) May decrease urinary flow, leading to urinary retention. High
Stress incontinence α-Blockers (Doxazosin, Prazosin, and Terazosin), anticholinergics, tricyclic antidepressants (imipramine hydrochloride, doxepin hydrochloride, and amitriptyline hydrochloride), and long-acting benzodiazepines May produce polyuria and worsening of incontinence. High
Arrhythmias Tricyclic antidepressants (imipramine hydrochloride, doxepin hydrochloride, and amitriptyline hydrochloride) Concern due to proarrhythmic effects and ability to produce QT interval changes. High
Insomnia Decongestants, theophylline (Theodur), methylphenidate (Ritalin), MAOIs, and amphetamines Concern due to CNS stimulant effects. High
Parkinson disease Metoclopramide (Reglan), conventional antipsychotics, and tacrine (Cognex) Concern due to their antidopaminergic/ cholinergic effects. High
Cognitive impairment Barbiturates, anticholinergics, antispasmodics, and muscle relaxants. CNS stimulants: dextroAmphetamine (Adderall), methylphenidate (Ritalin), methamphetamine (Desoxyn), and pemolin Concern due to CNS-altering effects. High
Depression Long-term benzodiazepine use. Sympatholytic agents: methyldopa (Aldomet), reserpine, and guanethidine (Ismelin May produce or exacerbate depression. High
Anorexia and malnutrition CNS stimulants: DextroAmphetamine (Adderall), methylphenidate (Ritalin), methamphetamine (Desoxyn), pemolin, and fluoxetine (Prozac) Concern due to appetite-suppressing effects. High
Syncope or falls Short- to intermediate-acting benzodiazepine and tricyclic antidepressants (imipramine hydrochloride, doxepin hydrochloride, and amitriptyline hydrochloride) May produce ataxia, impaired psychomotor function, syncope, and additional falls. High
SIADH/hyponatremia SSRIs: fluoxetine (Prozac), citalopram (Celexa), fluvoxamine (Luvox), paroxetine (Paxil), and sertraline (Zoloft) May exacerbate or cause SIADH. Low
Seizure disorder Bupropion (Wellbutrin) May lower seizure threshold. High
Obesity Olanzapine (Zyprexa) May stimulate appetite and increase weight gain. Low
COPD Long-acting benzodiazepines: chlordiazepoxide (Librium), chlordiazepoxide-amitriptyline (Limbitrol), clidiniumchlordiazepoxide (Librax), diazepam (Valium), quazepam (Doral), halazepam (Paxipam), and chlorazepate (Tranxene). β-blockers: propranolol CNS adverse effects. May induce respiratory depression. May exacerbate or cause respiratory depression. High
Chronic constipation Calcium channel blockers, anticholinergics, and tricyclic antidepressant (imipramine hydrochloride, doxepin hydrochloride, and amitriptyline hydrochloride) May exacerbate constipation. Low
< div class='tao-gold-member'>

Stay updated, free articles. Join our Telegram channel

Jul 11, 2016 | Posted by in NURSING | Comments Off on Medications and Older Adults

Full access? Get Clinical Tree

Get Clinical Tree app for offline access